School of Medicine
Showing 401-500 of 723 Results
-
Ross Metzger
Sr Res Scientist-Basic Life, Pediatrics - Cardiology
Current Research and Scholarly InterestsDevelopment, maintenance, and repair of the pulmonary circulation
-
D. Craig Miller, M.D.
Thelma and Henry Doelger Professor of Cardiovascular Surgery, Emeritus
Current Research and Scholarly InterestsCardiac and heart valve disease with experimental laboratory large animal projects focused on the investigation of left ventricular and cardiac mechanics, bioenergetics, and LV and mitral valve physiology and pathophysiology. Current thrust is aimed at understanding the mitral valve and subvalvular mitral apparatus and transmural LV wall strains, thickening, and myolaminar fiber-sheet mechanics.
Clinical research interests include thoracic aortic diseases (aortic dissection, aneurysm) and cardiac valvular disease, including surgical treatment, endovascular thoracic aortic stent-graft repair, mitral valve repair, and valve-sparing aortic root replacement. -
Lloyd B. Minor, MD
The Carl and Elizabeth Naumann Dean of the School of Medicine, Vice President for Medical Affairs, Stanford University, Professor of Otolaryngology - Head and Neck Surgery and Professor of Neurobiology and of Bioengineering, by courtesy
Current Research and Scholarly InterestsThrough neurophysiological investigations of eye movements and neuronal pathways, Dr. Minor has identified adaptive mechanisms responsible for compensation to vestibular injury in a model system for studies of motor learning. Following his discovery of superior canal dehiscence, he published a description of the disorder’s clinical manifestations and related its cause to an opening in the bone covering of the superior canal. He subsequently developed a surgical procedure to correct the problem.
-
R. Scott Mitchell
Professor of Cardiothoracic Surgery at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsResearch Interests: Disease of the aorta, congenital and acquired. Treatment of aortic pathology, including development of stent graft systems. Patterns of disease in patients treated with mediastinal radiation. Valvular heart disease, especially aortopathy associated with congenital bicuspid aortic valve.
-
Edward Mocarski
Professor of Microbiology and Immunology, Emeritus
Current Research and Scholarly InterestsMy research interests focused on the biology and pathogenesis of cytomegalovirus (CMV), an opportunistic pathogen that causes significant disease worldwide, reporting discoveries in areas of CMV gene regulation, DNA replication and packaging, maturation, impact on the host cell, disease pathogenesis, latency and reactivation, host cell death signaling and chemokine system. In the last 20 years of my academic career, we studied viral cell death suppressors and discovered ZBP1-RIPK3 necroptosis.
-
Daria Mochly-Rosen
George D. Smith Professor of Translational Medicine
Current Research and Scholarly InterestsTwo areas: 1. Using rationally-designed peptide inhibitors to study protein-protein interactions in cell signaling. Focus: protein kinase C in heart and large GTPases regulating mitochondrial dynamics in neurodegdenration. 2. Using small molecules (identified in a high throughput screens and synthetic chemistry) as activators and inhibitors of aldehyde dehydrogenases, a family of detoxifying enzymes, and glucose-6-phoshate dehydrogenase, in normal cells and in models of human diseases.
-
Stephen B. Montgomery
Stanford Medicine Professor of Pathology, Professor of Genetics and of Biomedical Data Science
Current Research and Scholarly InterestsWe focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with developing and utilizing state-of-the-art bioinformatics and statistical genetics approaches. See our website at http://montgomerylab.stanford.edu/
-
Ashby Morrison
Associate Professor of Biology
Current Research and Scholarly InterestsOur research interests are to elucidate the contribution of chromatin to mechanisms that promote genomic integrity.
-
Michael Moseley
Professor of Radiology (Radiological Sciences Lab)
Current Research and Scholarly InterestsMR physics into tissue contrast mechanisms such as diffusion, perfusion, and functional imaging describes the research direction. Applications of cerebral stroke (brain attacks) and neurocognitive disorders are also being developed from these methods
-
Kara Motonaga
Clinical Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsArrhythmias in Pediatric and Adult Congenital Heart Disease
-
Sesh Mudumbai
Associate Professor of Anesthesiology, Perioperative and Pain Medicine
On Leave from 05/05/2024 To 06/30/2024Current Research and Scholarly InterestsDr. Mudumbai’s research interests focus on 1) optimizing therapeutic strategies and reducing adverse outcomes related to medication management, particularly opioids; and 2) measuring and improving the quality of perioperative and pain management.
-
Adrienne Mueller
Associate Director of Scientific Education and Outreach, Cardiovascular Institute Operations
Current Role at StanfordAssociate Director of Scientific Education and Outreach
-
Claudia Mueller
Associate Professor of Surgery (Pediatric Surgery)
Current Research and Scholarly InterestsInvestigations of how children's beliefs of health affect their responses to illness.
-
Daniel Murphy
Professor of Pediatrics (Cardiology), Emeritus
Current Research and Scholarly InterestsDr. Murphy's major interests are in noninvasive cardiology and clinical pediatric and adult congenital cardiac disease. These clinical interests range from imaging of complex cardiac disease in the fetus and newborn to care of the adult with congenital heart disease. He also coordinates the Marfan clinic at LPCH. He is the director of the Adult Congenital Cardiac Clinic at Stanford University Medical Center.
-
Jonathan N. Myers
Clinical Professor (Affiliated), Medicine - Med/Cardiovascular Medicine
BioDr. Myers is a Health Research Scientist at the Palo Alto VA Health Care System; a Clinical Professor at Stanford University (Affiliated), and a Senior Research Career Scientist Award recipient through the VA Rehabilitation Research and Development Program. His research has focused on primary and secondary prevention, and the clinical applications of exercise testing and rehabilitation in patients with cardiovascular disease and other chronic conditions. He has a lengthy history of studying the epidemiology of cardiopulmonary exercise test responses, physical activity patterns, and other lifestyle factors and their relation to health outcomes. He manages the Veterans Exercise Testing Study (VETS), an ongoing, prospective evaluation of Veteran subjects referred for exercise testing for clinical reasons, designed to address exercise test, clinical, and lifestyle factors and their association with health outcomes.
He earned his bachelor’s degree from the University of California, Santa Barbara, his master's degree from San Diego State University, and his doctorate from the University of Southern California. He has been a board member for many organizations including the American Heart Association (AHA), the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), and the American College of Sports Medicine (ACSM), and serves on the editorial board for 9 journals. He is a recipient of the Michael Pollock Established Investigator Award through the AACVPR, a recipient of the Steven N Blair Award for excellence in physical activity research from the AHA Council on Epidemiology and Prevention and is the 2022 recipient of the American College of Sports Medicine Citation Award. He is a fellow of the AACVPR, ACSM, American College of Cardiology, and the AHA, and has authored and co-authored guidelines on exercise testing and rehabilitation for each of these organizations, including the 2021 editions of the ACSM and AACVPR guidelines. -
Ronjon Nag
Casual - Other Teaching Staff
BioRonjon Nag is an inventor, teacher and entrepreneur. He is an Adjunct Professor in Genetics at the Stanford School of Medicine, becoming a Stanford Distinguished Careers Institute Fellow in 2016. He teaches AI, Genes, Ethics, Longevity Science and Venture Capital. He is a founder and advisor/board member of multiple start-ups and President of the R42 Group, a venture capital firm which invests in, and creates, AI and Longevity companies. As an AI pioneer of smartphones and app stores, his companies have been sold to Apple, BlackBerry, and Motorola. More recently he has worked on the intersection of AI and Biology. He has been awarded the IET Mountbatten Medal by the Institution of Engineering and Technology, the 2021 IEEE-SCV Outstanding Engineer Award, the $1m Verizon Powerful Answers Award, the 2023 COX AI Lifetime Achievement Award, the 2023 MIT Great Dome Award, and is the 2024 Inductee in the Silicon Valley Engineering Hall of Fame. Professor Nag has a Ph.D from Cambridge, an M.S from Massachusetts Institute of Technology and a B.Sc. from Birmingham in the UK. He has numerous interests in the intersection of AI and Healthcare including being CEO of Agemica.ai working on creating a vaccine for aging.
He has many firsts including:
Firsts:
• First laptop with speech recognition built-in (with Apricot, 1984)
• First selling cursive handwriting recognition (with Lexicus, 1991)
• First speech recognition phones (with Lexicus/Motorola, 1996)
• First large-vocabulary Chinese speech recognition (with Lexicus/Motorola, 1996)
• First Chinese predictive text system on a phone (Lexicus/Motorola, 1997)
• First predictive text systems in 40 languages on Motorola phones, (Lexicus/Motorola, 1997)
• First touch screen mobile phone with handwriting recognition (Lexicus/Motorola, 1999)
• First combined mobile search engine and directory (with Cellmania, 2000)
• First private label downloadable operator billable apps store (Cellmania, 2000)
• First BlackBerry Operator Billing apps store (Cellmania,2010)
• First Neural Network Artificial Intelligence System in the Cloud (Ersatz Labs, 2014)
• First Throwable 360 Ball Camera (Bounce Imaging, 2015)
• First Android powered smart light switch (Brightswitch 2017)
• First blood pressure watch with temperature and pulse oximetry add-ons for Back to Work Covid Kit (GTCardio 2019)
• First no code AI life sciences app store (Superbio.ai 2022)
• First proposal for an aging vaccine (Agemica 2023) -
Priya Nair
Ph.D. Student in Bioengineering, admitted Autumn 2020
BioI received my Bachelor's degree in Biomedical Engineering with a minor in Industrial Design from Georgia Institute of Technology in 2020. During my time at Georgia Tech, I worked as an undergraduate researcher in Dr. Ajit Yoganathan's Cardiovascular Fluid Mechanics Lab. My project was focused on studying the contribution of foreign materials to thrombosis in transcatheter aortic valves using an in vitro flow loop. Beyond my research interests, I was also actively involved in the Society of Women Engineers, promoting outreach activities and creating mentorship opportunities for women in STEM.
-
Hiromitsu (Hiro) Nakauchi
Professor of Genetics (Stem Cell)
Current Research and Scholarly InterestsTranslation of discoveries in basic research into practical medical applications
-
Sandy Napel
Professor of Radiology (Integrative Biomedical Imaging Informatics), Emeritus
Current Research and Scholarly InterestsMy research seeks to advance the clinical and basic sciences in radiology, while improving our understanding of biology and the manifestations of disease, by pioneering methods in the information sciences that integrate imaging, clinical and molecular data. A current focus is on content-based radiological image retrieval and integration of imaging features with clinical and molecular data for diagnostic, prognostic, and therapy planning decision support.
-
Sanjiv Narayan
Professor of Medicine (Cardiovascular Medicine)
On Partial Leave from 09/05/2023 To 06/30/2024Current Research and Scholarly InterestsDr. Narayan directs the Computational Arrhythmia Research Laboratory, whose goal is to define the mechanisms underlying complex human heart rhythm disorders, to develop bioengineering-focused solutions to improve therapy that will be tested in clinical trials. The laboratory has been funded continuously since 2001 by the National Institutes of Health, AHA and ACC, and interlinks a disease-focused group of clinicians, computational physicists, bioengineers and trialists.
-
Shingo Narita
Postdoctoral Scholar, Cardiovascular Institute
BioPostdoctoral Fellow
Cardiologist (Japan) -
Drew Nelson
Professor of Mechanical Engineering, Emeritus
BioResearch involves development of improved methods for predicting the fatigue life of engineering materials, incuding the effects of manufacturing processes, and investigation of new approaches in the field of experimental mechanics, such as determination of residual stresses using optical methods.
-
Mark Nicolls
Stanford University Professor of Pulmonary and Critical Care Medicine
Current Research and Scholarly InterestsOur lab focuses primarily on the contribution of the immune response to lung disease. We are specifically examining the contribution of inflammation to the development of vascular injury in transplantation, pulmonary hypertension and lymphedema.
-
Koen Nieman
Professor of Medicine (Cardiovascular Medicine) and of Radiology (CV Imaging)
Current Research and Scholarly InterestsDr Nieman investigates advanced cardiac imaging techniques. Current projects focus on the development of functional CT application for hemodynamic interpretation of coronary artery disease, and the clinical validation of cardiac CT in the management of patients with ischemic heart disease.
-
Masataka Nishiga
Instructor, Cardiovascular Institute
BioDr. Nishiga is an Instructor at the Stanford Cardiovascular Institute. As a physician-scientist, he focuses on unraveling the mechanisms of cardiovascular diseases and developing innovative treatments. His research path was sparked by firsthand experiences with heart failure patients during his clinical practice, where he recognized the urgent need for more effective treatments. After completing his cardiology fellowship in Japan, he pursued a Ph.D. at Kyoto University, focusing on the role of microRNAs and non-coding RNAs in heart failure, cardiac fibrosis, and atherosclerosis. Currently at Stanford and under the guidance of Dr. Joseph Wu, Dr. Nishiga's postdoctoral research leverages iPSCs and CRISPR technology. His primary research areas include the cardiac impacts of cancer therapies, the cardiovascular effects of COVID-19, and the influence of marijuana use on vascular inflammation.
-
Dwight Nishimura
Addie and Al Macovski Professor, Emeritus
Current Research and Scholarly Interestsmedical imaging, magnetic resonance imaging
-
Joyce Njoroge, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Njoroge is a board-certified physician and fellowship-trained cardiologist with the Advanced Heart Failure Program at Stanford Health Care. She is also a clinical assistant professor of medicine in the Division of Cardiovascular Medicine.
Dr. Njoroge has extensive clinical experience diagnosing and treating cardiovascular complications that develop during pregnancy or postpartum. She currently provides care at the Stanford Health Care Heart and Vascular Clinic with a particular focus on patients with a history of pregnancy-associated heart failure and cardiomyopathy.
Dr. Njoroge’s research efforts involve identifying inherited genetic changes and biological markers that could help improve screening and care for pregnant women in higher risk populations. This includes determining the causes of disproportionately high incidences of heart-related complications and deaths experienced by Black women during and after pregnancy. Dr. Njoroge is also currently recruiting patients for a large-scale, multicenter clinical trial evaluating a drug to treat cardiovascular complications during pregnancy.
Dr. Njoroge has published her work in numerous prestigious peer-reviewed journals, including Circulation Research and the Journal of Cardiac Failure. She also co-authored a chapter on cardiovascular disease in pregnancy in the most recent edition of the book Current Diagnosis and Treatment: Cardiology.
Dr. Njoroge is a member of the Association of Black Cardiologists, the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America. -
Chikage Noishiki, MD, PhD
Postdoctoral Scholar, Cardiovascular Institute
BioDoctor of Philosophy, Nippon Medical School, Tokyo, Japan (2019)
Doctor of Medicine, Dokkyo university, Tochigi, Japan (2010)
Board Certified in Plastic and Reconstructive Surgery, Japan (2020)
Fellowship, Plastic and Reconstructive Surgery, Nippon Medical School, Tokyo, Japan (2016) -
Ruth O'Hara
Director, Spectrum, Senior Associate Dean, Research and Lowell W. and Josephine Q. Berry Professor
Current Research and Scholarly InterestsDr. O'Hara's research aims to investigate how cognitive information processing deficits subserve affective symptoms in psychiatric disorders, and interact with key brain networks integral to these disorders. To do so, she has implemented a translational, interdisciplinary program that encompasses cellular models, brain and behavioral assays of affective and cognitive information processing systems in psychiatric disorders across the lifespan.
-
Daryl Oakes
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr Oakes is a Clinical Professor at Stanford School of Medicine with over 17 years of clinical experience in cardiothoracic anesthesiology. Dr. Oakes is Associate Dean of Post Graduate Medical Education and the Stanford Center of CME and Vice Chair of Clinical Educator Affairs in the Department of Anesthesiology.
The focus of her academic work has been the education and training of anesthesiologists at all levels of practice. In 2007 developed an education pathway for Stanford anesthesiology residents to learn perioperative echocardiography, one of the first programs of its kind nationally. She has since taught echocardiography to medical students, residents and fellows and lectures nationally on a range of topics related to transesophageal echocardiography, cardiothoracic anesthesiology, and medical education. In 2017, she was appointed Program Director of the Stanford Adult Cardiothoracic Anesthesiology Fellowship, and, under her 6 years of leadership, the program expanded from 4 fellows to 8 fellows and became widely recognized as one of the highest quality and most sought after programs nationally, consistently attracting a highly diverse group of fellowship candidates.
In 2018 Dr. Oakes was appointed Associate Dean of Postgraduate Medical Education and took over leadership of the Stanford Center of Continue Medical Education. Under her leadership the center has greatly expanded its programming and impact and Stanford CME is now universally regarded as the academic leader in continuing medical education. In addition to providing traditional meeting services and program accreditation, the office has taken the lead on several innovative educational programs including a statewide effort to that provided training to providers in over 1000 nursing homes on protecting their elderly residents from COVID, a virtual digital conference AI + Health reaching over 1000 participants, and several programs addressing health care disparities and justice, equity, diversity and inclusion efforts.
Dr. Oakes is a passionate mentor to both trainees and colleagues and has created multiple programs to support physician professional development including most recently, the Stanford CME Physician Leadership Certificate Program, a 6-month cohort-based leadership training for aspiring and developing physician leaders. She also co-founded and chairs the SCA Women in Cardiothoracic Anesthesiology (WICTA) Special Interest Group and has been recognized for her work supporting women medical professionals with the 2021Women in Medicine (WIM) #SheForShe Award and the 2023 WICTA “SHE LEADS” Award. Dr. Oakes is a recognized leader in her field and elected member of the Association of University Anesthesiologists (AUA). -
Michelle Odden
Associate Professor of Epidemiology and Population Health
Current Research and Scholarly InterestsMultilevel - from cells to society - epidemiologic study of healthy aging
-
Yoshikazu Ono
Visiting Instructor/Lecturer, Cardiothoracic Surgery
BioYoshikazu Ono is a pediatric cardiovascular surgeon who is board certified by The Japanese Board of Cardiovascular Surgery.
He graduated from Nagoya City University in 2015 and began his internship at Nagoya City East Medical Center. He then completed his residency in cardiovascular surgery at the National Cerebral and Cardiovascular Center. He completed a fellowship in pediatric cardiovascular surgery at the same institution after a three-year residency.
His main interests are congenital cardiac defects and mechanical support in children. He is dedicated to improving the safety and durability of surgical treatments and ventricular assist devices for these patients. -
Marily Oppezzo
Instructor, Medicine - Stanford Prevention Research Center
BioMarily Oppezzo is a behavioral and learning scientist. She completed her doctorate in Educational Psychology at Stanford in 2013. She also is a registered dietitian and has her master's of nutritional science. She completed her dietetic internship at the Palo Alto Veterans Hospital, and currently consults as a sports dietitian for Stanford's Runsafe program. Her research interests leverage her interdisciplinary training, with a focus on how to get people to change to improve their health and well-being. Specifically, these areas include: using social media to motivate physical activity changes in those with or at risk for heart disease; culturally tailoring nutrition and physical activity recommendations and education materials for an Alaskan native population; how walking can be used to improve people's cognitive and creative thinking; and applying learning theories to medical education topics.
-
Doug Owens
Henry J. Kaiser, Jr. Professor, Senior Fellow at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of Management Science and Engineering
Current Research and Scholarly InterestsMy research uses decision modeling, cost-effectiveness analysis, and meta-analysis to evaluate clinical and health policy problems. Much of my work involves development of national guidelines for prevention and treatment.
-
Philip Oyer
Roy B. Cohn-Theodore A. Falasco Professor of Cardiothoracic Surgery, Emeritus
Current Research and Scholarly InterestsDevelopment of an artificial heart assist device; heart, and heart-lung transplantation.
-
Latha Palaniappan, MD, MS
Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Palaniappan has published over 200 peer reviewed manuscripts, abstracts, and book chapters over the last 20 years in the areas of chronic disease prevention and treatment in diverse populations. She has expertise in epidemiological research using big data, use of electronic health records for research, and clinical trials.
-
Alan C. Pao
Associate Professor of Medicine (Nephrology) and, by courtesy, of Urology
Current Research and Scholarly InterestsWe are broadly interested in how the kidneys control salt, water, and electrolyte homeostasis in the body. Our disease focus is on kidney stone disease. We use cultured kidney cells, transgenic mice, human plasma/urine samples, and electronic health record data to study the pathogenesis of kidney stone disease. Our therapeutic focus is on the development of small molecule compounds that can be used for kidney stone prevention.
-
Vedant Pargaonkar
Basic Life Research Scientist, Medicine - Med/Cardiovascular Medicine
BioMy long-term research interests involve development of algorithms using computational methods for early detection of coronary pathophysiology including, endothelial dysfunction and microvascular dysfunction (MVD) and/or a myocardial bridge (MB) in patients with angina and no obstructive coronary artery disease (NOCAD) and the identification of novel target therapies for primary prevention and improved prognosis in these patients. Under the mentorship of Dr. Jennifer Tremmel in Cardiovascular medicine at Stanford, I have been systematically studying to better understand the underlying pathophysiology of these patients, as well as the optimal use of diagnostic testing and treatment using the angina and no-obstructive CAD Registry at Stanford. In collaboration with other investigators in this field, we have published multiple scientific articles highlighting the limitations of current testing in this population and identification of novel diagnostic tools for early diagnosis and management of patients with angina and no obstructive CAD. My research also focuses on myocardial infarction (MI) in women, particularly spontaneous coronary artery dissection (SCAD). I have been involved in the design and execution of the first international collaborative study in SCAD, investigating peripartum vs. non-peripartum SCAD. This is analyzing the largest cohort of patients recruited from multiple US and non-US sites to understand the pathophysiological differences in these patient cohorts.
-
Victoria Parikh
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Parikh is a clinician scientist who cares for patients with and studies inherited (genetic) cardiovascular disease. She is the director of the Stanford Center for Inherited Cardiovascular Disease (SCICD) which is one of the largest of its kind in the country. SCICD integrates clinical and basic science with the expert care of patients with genetic cardiovascular conditions (e.g., cardiomyopathies, arrhythmias and vascular diseases). It provides cutting edge care for thousands of patients and families across the lifespan and integrates medical, surgical and genetics care. Our team includes physicians, nurses, advanced practice providers, genetic counselors, exercise physiologists and scientists.
Dr. Parikh's own clinical practice and laboratory are focused on the genetics of cardiomyopathies and their associated arrhythmogenic substrates. She completed clinical cardiology fellowship at Stanford School of Medicine and her medical residency at the University of California, San Francisco. Funded by multiple research grants from the NIH, her lab seeks to identify novel mechanisms and therapeutic technologies for genetic cardiomyopathy as well as better understand the natural histories of patients affected by these diseases. -
Chirag Patel, MD, PhD
Member, Cardiovascular Institute
Current Research and Scholarly InterestsNeuro-oncology, Clinical Trials, Tumor Treating Fields (TTFields), Molecular/PET Imaging, Neuroimaging, Immunotherapy, Big Data Analysis
-
Meghna Patel
Clinical Assistant Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsMy current academic focus is in chronic heart failure and ventricular assist device.
-
Arogyaswami Paulraj
Professor (Research) of Electrical Engineering, Emeritus
BioProfessor Emeritus Arogyaswami Paulraj, Stanford University, is a pioneer of MIMO wireless communications, a technology break through that enables improved wireless performance. MIMO is now incorporated into all new wireless systems.
Paulraj is the author of over 400 research papers, two textbooks, and a co-inventor in 80 US patents.
Paulraj has won over a dozen awards, notably the National Inventors Hall of Fame (USPTO), Marconi Prize and Fellowship, 2014 and the IEEE Alexander Graham Bell Medal, 2011. He is a fellow of eight scientific / engineering national academies including the US, China, India, and Sweden. He is a fellow of IEEE and AAAS.
In 1999, Paulraj founded Iospan Wireless Inc. - which developed and established MIMO-OFDMA wireless as the core 4G technology. Iospan was acquired by Intel Corporation in 2003. In 2004, he co-founded Beceem Communications Inc. The company became the market leader in 4G-WiMAX semiconductor and was acquired by Broadcom Corp. in 2010. In 2014 he founded Rasa Networks to develop Machine Learning tools for WiFi Networks. The company was acquired HPE in 2016.
During his 30 years in the Indian (Navy) (1961-1991), he founded three national-level laboratories in India and headed one of India’s most successful military R&D projects – APSOH sonar. He received over a dozen awards (many at the national level) in India including the Padma Bhushan, Ati Vishist Seva Medal and the VASVIK Medal. -
John M. Pauly
Reid Weaver Dennis Professor
BioInterests include medical imaging generally, and magnetic resonance imaging (MRI) in particular. Current efforts are focused on medical applications of MRI where real-time interactive imaging is important. Two examples are cardiac imaging, and the interactive guidance of interventional procedures. Specific interests include rapid methods for the excitation and acquisition of the MR signal, and the reconstruction of images from the data acquired using these approaches.
-
Ronald Pearl
Dr. Richard K. and Erika N. Richards Professor
Current Research and Scholarly InterestsMechanims (molecular and cellular) of pulmonary hypertension, treatment of pulmonary hypertension, treatment of respiratory failure, treatment of septic shock, hemodynamic monitoring
-
Norbert Pelc
Boston Scientific Applied Biomedical Engineering Professor and Professor of Radiology, Emeritus
Current Research and Scholarly InterestsBroadly, Dr. Pelc is interested in the physics, engineering and mathematics of medical imaging, especially computed tomography, digital x-ray imaging, magnetic resonance imaging, and hybrid multimodality systems. His current research is concentrated in the development of computed tomography systems with higher image quality and dose efficiency, in the characterization of system performance, and in the development and validation of new clinical applications.
-
Allison Peng
Affiliate, Department Funds
Resident in Graduate Medical EducationCurrent Research and Scholarly InterestsMy research interests are in preventive cardiology and cardiovascular imaging, and in particular coronary artery calcium. I am also interested in the intersection of radiology and biomedical data science with the goals of improving detection of subclinical ASCVD, stratification of cardiovascular risk, and implementation of equitable population-wide preventive intervention.
-
Marco Perez
Associate Professor of Medicine (Cardiovascular Medicine)
BioDr. Marco Perez's research goal is to better understand the fundamental causes of cardiovascular disease through the study of genetics and epidemiology. His group studies the genetic variations and environmental exposures that are associated with conditions such as atrial fibrillation and heart failure. He has led the studies of atrial fibrillation in Women's Health Initiative, one of the largest nation-wide population-based cohorts. He is currently conducting a large study monitoring for silent or asymptomatic atrial fibrillation in women from the WHI randomized to exercise intervention, and was co-PI of the Apple Heart Study, a clinical trial that validated the ability of a smartwatch to detect atrial fibrillation. He is now PI of the Clinical Coordinating Center at Stanford for the REACT-AF which is a clinical trial to evaluate efficacy and safety of a "pill-in-the pocket" approach to anticoagulation for AF using a smartwatch. He is interested in understanding the paradox that atrial fibrillation is less common in African Americans and Hispanics, despite a greater burden of risk factors such as hypertension. As director of the Stanford Inherited Arrhythmia Clinic, he evaluates families with rare inherited arrhythmias associated with sudden death such as Long QT and Brugada Syndromes and explores their links with novel genes. He also studies the genetic causes of very early onset atrial fibrillation. He also studies how best to use the electrocardiogram and imaging modalities using Machine Learning techniques to identify patients at risk for cardiovascular disease. Dr. Perez receives funding from the NIH/NHLBI, Apple Inc., Janssen and the Colson Foundation.
-
Alexander C. Perino
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioAlexander C. Perino MD is a cardiac electrophysiologist, clinical informaticist, and cardiovascular researcher. In his clinical role, Dr. Perino treats patients with heart rhythm disorders at Stanford Health Care, performing catheter ablations and cardiac device implantations. In addition to complex ablation (e.g., atrial fibrillation and ventricular tachycardia ablation), Dr. Perino has expertise implanting leadless pacemakers, subcutaneous ICDs, and conduction system pacing leads (i.e., His bundle and left bundle branch area pacing leads). Dr. Perino is the medical informatics director for the Division of Cardiovascular Medicine at Stanford Health Care, providing informatics direction to improve 1) the quality and safety of cardiovascular care delivery and 2) patient and clinician experience derived from the electronic health record and related information and communication technologies. As a cardiovascular researcher, Dr. Perino uses large datasets to examine quality of care, outcomes, and risk prediction for heart rhythm disorders and cardiovascular disease.
-
VJ Periyakoil, Professor of Medicine
Professor of Medicine (Primary Care and Population Health)
Current Research and Scholarly InterestsMy research focuses on the intersection of biological, psychosocial and cultural aspects of care of persons with chronic and serious illnesses including dementia.
-
Mark Perlroth, MD
Member, Cardiovascular Institute
Current Research and Scholarly Interests1. Adult Congenital Heart Disease
2. Cardiac Transplantation
3. General Cardiology
4. Porphyrias -
Ed Petrossian
Clinical Professor, Cardiothoracic Surgery
Current Research and Scholarly InterestsDr. Petrossian has expertise in complex pediatric and congenital cardiovascular surgical repairs. He has published several journal articles and book chapters with an emphasis on the extracardiac conduit Fontan operation.
-
Martin Pfaller
Instructor, Pediatrics - Cardiology
BioMartin R. Pfaller is an Instructor in the Department of Pediatrics (Cardiology) in the group of Alison L. Marsden. He received his B.Sc., M.Sc., and Ph.D. in Mechanical Engineering from the Technical University of Munich, working with Wolfgang A. Wall. During his Ph.D., he validated an efficient yet physiologically accurate boundary condition to account for the mechanical support of the heart within its surroundings, which has been adopted by various research groups worldwide. He further demonstrated how projection-based model order reduction could speed up model personalization from patient data, such as magnetic resonance imaging or blood pressure measurements. His current work focuses on cardiovascular fluid dynamics. He developed reduced-physics models to make blood flow simulations faster and more reliable. Further, he developed a fluid-solid-growth interaction model in blood vessels. His future research will predict the heart’s long-term function in heart diseases, supported by an NIH Pathway to Independence Award (K99/R00) and Stanford MCHRI Instructor K Award Support. He will quantify the risk of heart failure after a heart attack with a stability analysis validated with imaging data in swine and humans. This research will improve our understanding of biomechanical mechanisms leading to heart failure and help to identify patients at risk, enable personalized therapies, and facilitate the optimal design of medical devices. As an Assistant Professor, Martin will start his research group at Yale University in the Department of Biomedical Engineering in July 2024.
-
Ada Poon
Associate Professor of Electrical Engineering
Current Research and Scholarly InterestsOur research focuses on providing theoretical foundations and engineering platforms for realizing electronics that seamlessly integrate with the body. Such systems will allow precise recording or modulation of physiological activity, for advancing basic scientific discovery and for restoring or augmenting biological functions for clinical applications.
-
Richard Popp
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsAcademic-Industrial relations; Ethics of invention.
-
Matthew Porteus
Sutardja Chuk Professor of Definitive and Curative Medicine
BioDr. Porteus was raised in California and was a local graduate of Gunn High School before completing A.B. degree in “History and Science” at Harvard University where he graduated Magna Cum Laude and wrote an thesis entitled “Safe or Dangerous Chimeras: The recombinant DNA controversy as a conflict between differing socially constructed interpretations of recombinant DNA technology.” He then returned to the area and completed his combined MD, PhD at Stanford Medical School with his PhD focused on understanding the molecular basis of mammalian forebrain development with his PhD thesis entitled “Isolation and Characterization of TES-1/DLX-2: A Novel Homeobox Gene Expressed During Mammalian Forebrain Development.” After completion of his dual degree program, he was an intern and resident in Pediatrics at Boston Children’s Hospital and then completed his Pediatric Hematology/Oncology fellowship in the combined Boston Chidlren’s Hospital/Dana Farber Cancer Institute program. For his fellowship and post-doctoral research he worked with Dr. David Baltimore at MIT and CalTech where he began his studies in developing homologous recombination as a strategy to correct disease causing mutations in stem cells as definitive and curative therapy for children with genetic diseases of the blood, particularly sickle cell disease. Following his training with Dr. Baltimore, he took an independent faculty position at UT Southwestern in the Departments of Pediatrics and Biochemistry before again returning to Stanford in 2010 as an Associate Professor. During this time his work has been the first to demonstrate that gene correction could be achieved in human cells at frequencies that were high enough to potentially cure patients and is considered one of the pioneers and founders of the field of genome editing—a field that now encompasses thousands of labs and several new companies throughout the world. His research program continues to focus on developing genome editing by homologous recombination as curative therapy for children with genetic diseases but also has interests in the clonal dynamics of heterogeneous populations and the use of genome editing to better understand diseases that affect children including infant leukemias and genetic diseases that affect the muscle. Clinically, Dr. Porteus attends at the Lucille Packard Children’s Hospital where he takes care of pediatric patients undergoing hematopoietic stem cell transplantation.
-
Guillem Pratx
Associate Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsThe Physical Oncology Lab is interested in making a lasting impact on translational cancer research by building novel physical tools and methods.
-
James Priest
Adjunct Clinical Assistant Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsThe Priest lab seeks a better understanding of the genetics and pathogenesis of congenital heart disease using translational genomics, big-data, and vertebrate models of cardiac development.
-
Lei (Stanley) Qi
Associate Professor of Bioengineering
BioDr. Lei (Stanley) Qi is Associate Professor of Bioengineering, Sarafan ChEM-H, and a Chan Zuckerberg Biohub Investigator. Dr. Qi is a principal contributor to the development of CRISPR technologies for genome engineering beyond gene editing. His lab created the first nuclease-deactivated Cas9 (dCas9) for targeted gene regulation in cells. His lab has invented a CRISPR toolbox for engineering the epigenome, including CRISPRi and CRISPRa for targeted gene repression and activation, epigenome editing, LiveFISH for real-time DNA/RNA imaging, CRISPR-GO for 3D genome manipulation, CasMINI as a compact CRISPR system for gene therapy, hyperCas12a for multi-gene engineering, and CRISPR antivirals aimed at treating broad RNA viruses.
Dr. Qi obtained B.S. in Physics and Math from Tsinghua University in 2005, and Ph.D. in Bioengineering from the University of California, Berkeley in 2012. He was a Systems Biology Faculty Fellow at UCSF between 2012-2014, and joined Stanford faculty in 2014. His research focuses on mammalian synthetic biology, epigenetic engineering, immune cell engineering, directed evolution, and novel approaches for gene therapy.